esomeprazole + sildenafil citrate

Esomeprazole + sildenafil citrate is a combination of two small molecule drugs, each with distinct mechanisms of action and clinical indications. Esomeprazole is a proton pump inhibitor (PPI) that suppresses gastric acid secretion by irreversibly inhibiting the (H+, K+)-ATPase enzyme in gastric parietal cells, leading to reduced stomach acidity. It is primarily used for gastroesophageal reflux disease (GERD), peptic ulcer disease, H. pylori eradication regimens, prevention of NSAID-induced gastrointestinal injury, and other acid-related disorders[2][8]. Sildenafil citrate is a phosphodiesterase-5 (PDE5) inhibitor that increases cyclic GMP levels by inhibiting PDE5 in smooth muscle tissue; this results in vasodilation and increased blood flow. Sildenafil's main indications are erectile dysfunction and pulmonary arterial hypertension[4][6]. There are no known clinically significant interactions between these two drugs when co-administered[1][3].

Other names

esomeprazole and sildenafil citrateesomeprazole + sildenafil